{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T11:30:01Z","timestamp":1785583801428,"version":"3.56.0"},"reference-count":24,"publisher":"The Endocrine Society","issue":"7","license":[{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Wuxi \u201cDouble Hundred\u201d Young and Middle-aged Medical and Healthcare Talents Cultivation Program","award":["BJ2023047"],"award-info":[{"award-number":["BJ2023047"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Euglycemic diabetic ketoacidosis (EDKA) is a type of DKA whose incidence has increased in recent years because of the widespread use of sodium-glucose transport protein 2 inhibitors in diabetes treatment. However, the concomitant occurrence of a thyroid storm is uncommon, easily misdiagnosed and missed, and has a high risk of death. This report described the case of a 46-year-old woman with type 2 diabetes mellitus who used a sodium-glucose transport protein 2 inhibitor to manage her blood glucose levels. Before undergoing hysteroscopic surgery for a uterine mass, she developed EDKA and thyroid storm after experiencing nausea, vomiting, and a high fever with persistent tachycardia. This report summarizes and analyzes the clinical characteristics, diagnosis, and treatment process and outcomes to accumulate clinical experience and improve clinicians' understanding of this acute and life-threatening disease. Timely and appropriate treatment may help reduce the incidence of morbidity and mortality associated with EDKA and thyroid storm.<\/jats:p>","DOI":"10.1210\/jcemcr\/luaf086","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T08:13:12Z","timestamp":1747815192000},"source":"Crossref","is-referenced-by-count":1,"title":["Euglycemic Diabetic Ketoacidosis and Thyroid Storm Occurring During Dapagliflozin Treatment"],"prefix":"10.1210","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-6305-3698","authenticated-orcid":false,"given":"Ning","family":"Bai","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Affiliated Hospital of Jiangnan University , Wuxi, Jiangsu Province 214000 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7984-1904","authenticated-orcid":false,"given":"Nan","family":"Wang","sequence":"additional","affiliation":[{"name":"Wuxi School of Medicine, Jiangnan University , Wuxi, Jiangsu Province 214122 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0351-7967","authenticated-orcid":false,"given":"Ya","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Affiliated Hospital of Jiangnan University , Wuxi, Jiangsu Province 214000 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4629-9883","authenticated-orcid":false,"given":"Jian","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Affiliated Hospital of Jiangnan University , Wuxi, Jiangsu Province 214000 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"key":"2025052104130689700_luaf086-B1","first-page":"281","article-title":"Concerns about non-hyperglycemic ketoacidosis induced by sodium-glucose transporter protein 2 inhibitors","volume":"23","author":"Ji","year":"2021","journal-title":"J Adverse Drug React"},{"key":"2025052104130689700_luaf086-B2","first-page":"697","article-title":"Research progress of non-hyperglycemic diabetic ketoacidosis","volume":"42","author":"Chen","year":"2022","journal-title":"Chin Emerg Med"},{"key":"2025052104130689700_luaf086-B3","doi-asserted-by":"crossref","first-page":"828649","DOI":"10.3389\/fsurg.2022.828649","article-title":"New diabetic medication sodium-glucose cotransporter-2 inhibitors can induce euglycemic ketoacidosis and mimic surgical diseases: a case report and review of literature","volume":"9","author":"Kietaibl","year":"2022","journal-title":"Front Surg"},{"issue":"3","key":"2025052104130689700_luaf086-B4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/1573399812666160421121307","article-title":"Euglycemic diabetic ketoacidosis: a review","volume":"13","author":"Modi","year":"2017","journal-title":"Curr Diabetes Rev"},{"issue":"9","key":"2025052104130689700_luaf086-B5","first-page":"428","article-title":"Progress of clinical research on diabetes mellitus and thyroid disease","volume":"8","author":"Li","year":"2014","journal-title":"Diabetes Clin"},{"issue":"02","key":"2025052104130689700_luaf086-B6","first-page":"105","article-title":"Evaluation on the clinical application of huganning tablets","volume":"13","author":"Song","year":"2013","journal-title":"Eval Anal Drug Use Hosp China"},{"issue":"1","key":"2025052104130689700_luaf086-B7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/dom.13012","article-title":"Sodium-glucose co-transporter-2 inhibitors and diabetic ketoacidosis: an updated review of the literature","volume":"20","author":"Bonora","year":"2018","journal-title":"Diabetes Obes Metab"},{"issue":"19","key":"2025052104130689700_luaf086-B8","first-page":"1265","article-title":"Euglycemic ketoacidosis\u2014rare condition on the rise","volume":"146","author":"Kampmeyer","year":"2021","journal-title":"Dtsch Med Wochenschr"},{"issue":"2","key":"2025052104130689700_luaf086-B9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/jdi.12401","article-title":"Euglycemic diabetic ketoacidosis induced by SGLT2 inhibitors: possible mechanism and contributing factors","volume":"7","author":"Ogawa","year":"2016","journal-title":"J Diabetes Investig"},{"issue":"8","key":"2025052104130689700_luaf086-B10","doi-asserted-by":"crossref","first-page":"e2924","DOI":"10.1002\/dmrr.2924","article-title":"Ketoacidosis associated with SGLT2 inhibitor treatment: analysis of FAERS data","volume":"33","author":"Blau","year":"2017","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"2025052104130689700_luaf086-B11","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-physiol-021113-170343","article-title":"The molecular physiology of uric acid homeostasis","volume":"77","author":"Mandal","year":"2015","journal-title":"Annu Rev Physiol"},{"issue":"6","key":"2025052104130689700_luaf086-B12","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1080\/14740338.2020.1764532","article-title":"Euglycaemic diabetic ketoacidosis as a complication of SGLT-2 inhibitors: epidemiology, pathophysiology, and treatment","volume":"19","author":"Sampani","year":"2020","journal-title":"Expert Opin Drug Saf"},{"issue":"3","key":"2025052104130689700_luaf086-B13","doi-asserted-by":"crossref","first-page":"927","DOI":"10.4103\/jfmpc.jfmpc_644_21","article-title":"Euglycemic diabetic ketoacidosis associated with SGLT2 inhibitors: a systematic review and quantitative analysis","volume":"11","author":"Dutta","year":"2022","journal-title":"J Family Med Prim Care"},{"issue":"6","key":"2025052104130689700_luaf086-B14","doi-asserted-by":"crossref","first-page":"102275","DOI":"10.1016\/j.dsx.2021.102275","article-title":"Clinical and biochemical characteristics and analysis of risk factors for euglycaemic diabetic ketoacidosis in type 2 diabetic individuals treated with SGLT2 inhibitors: a review of 72 cases over a 4.5-year period","volume":"15","author":"Menghoum","year":"2021","journal-title":"Diabetes Metab Syndr"},{"issue":"16","key":"2025052104130689700_luaf086-B15","first-page":"1542","article-title":"Multiple organ failure caused by thyroid storm and diabetes ketoacidosis following radioactive iodine-131 treatment: a case report","volume":"44","author":"Wang","year":"2023","journal-title":"J Qiqihar Univ Med"},{"issue":"9","key":"2025052104130689700_luaf086-B16","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1016\/j.ajem.2012.01.003","article-title":"Successful treatment of thyroid crisis accompanied by hypoglycemia, lactic acidosis, and multiple organ failure","volume":"30","author":"Deng","year":"2012","journal-title":"Am J Emerg Med"},{"issue":"3","key":"2025052104130689700_luaf086-B17","doi-asserted-by":"crossref","first-page":"254","DOI":"10.4158\/EP.15.3.254","article-title":"Excess thyroid hormone and carbohydrate metabolism","volume":"15","author":"Potenza","year":"2009","journal-title":"Endocr Pract"},{"issue":"4","key":"2025052104130689700_luaf086-B18","first-page":"e58696","article-title":"The interconnectedness of euglycemic diabetic ketoacidosis with concomitant thyroid storm: a case report","volume":"16","author":"Strawn","year":"2024","journal-title":"Cureus"},{"key":"2025052104130689700_luaf086-B19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/5584_2020_545","article-title":"Acute metabolic emergencies in diabetes: DKA, HHS and EDKA","volume":"1307","author":"Muneer","year":"2021","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"2025052104130689700_luaf086-B20","doi-asserted-by":"crossref","first-page":"753","DOI":"10.4158\/EP161292.PS","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology position statement on the association of sglt-2 inhibitors and diabetic ketoacidosis","volume":"22","author":"Handelsman","year":"2016","journal-title":"Endocr Pract"},{"issue":"1","key":"2025052104130689700_luaf086-B21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1089\/pancan.2018.0016","article-title":"Euglycemic diabetic ketoacidosis due to sodium-glucose cotransporter 2 inhibitor use in two patients undergoing pancreatectomy","volume":"4","author":"Pace","year":"2018","journal-title":"J Pancreat Cancer"},{"issue":"2","key":"2025052104130689700_luaf086-B22","doi-asserted-by":"crossref","first-page":"2324709617710040","DOI":"10.1177\/2324709617710040","article-title":"Prolonged ketosis in a patient with euglycemic diabetic ketoacidosis secondary to dapagliflozin","volume":"5","author":"Pujara","year":"2017","journal-title":"J Investig Med High Impact Case Rep"},{"issue":"4","key":"2025052104130689700_luaf086-B23","first-page":"e4496","article-title":"Post-surgical euglycemic diabetic ketoacidosis in a patient on empagliflozin in the intensive care unit","volume":"11","author":"Bteich","year":"2019","journal-title":"Cureus"},{"key":"2025052104130689700_luaf086-B24","author":"Xue"}],"container-title":["JCEM Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/3\/7\/luaf086\/63256943\/luaf086.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/3\/7\/luaf086\/63256943\/luaf086.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T08:13:16Z","timestamp":1747815196000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcemcr\/article\/doi\/10.1210\/jcemcr\/luaf086\/8139701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,5,15]]}},"URL":"https:\/\/doi.org\/10.1210\/jcemcr\/luaf086","relation":{},"ISSN":["2755-1520"],"issn-type":[{"value":"2755-1520","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2025,5,15]]},"article-number":"luaf086"}}